Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
By A. Dignass, J. Lindsay, A. Sturm, A. Windsor, J. Colombel, M. Allez, G. D'Haens, A. D'hoore, G. Mantzaris, G. Novacek and 7 more. Journal of Crohn's & Colitis, 2012
1,275 citations recorded by the source corpus.
Subfields: Epidemiology, Genetics
View Paper: https://www.semanticscholar.org/paper/e9fae4ff75dfd96e8c6d2a12cd2faeb9dd6c025d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
Citations in the corpus
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. (2017, methodology): “Conditions predisposing to OIs are classified according to the Center for Disease Control362 as: [1] severe immune-depression; [2] human immunodeficiency virus [HIV]-infection related; and [3] limited immune deficits.”
- The gut microbiota and host health: a new clinical frontier (2015, background): “73 There are two published clinical trials of the multistrain probiotic VSL”
- Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome (2019, background): “The guidelines are very cautious in defining the exact role of prebiotics in IBD and do not allow the use of prebiotics in either UC or CD [231].”